TIMES ARROW
IDEXX Laboratories Inc(IDXX)
Exchange:NASDAQ
Sector:Healthcare
Industry:
Diagnostics & Research
Operation:
Domestic
IPO Date:
1991-06-21
Employees:
11,000
Url:
https://www.idexx.com
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
Financial Ratios Overview (2023)
Current Ratio
1.57
Acid-Test Ratio
1.17
Cash Ratio
0.48
Operating Cash Flow Ratio
0.95
Debt Ratio
0.64
Interest Coverage Ratio
30.52
Debt Service Coverage Ratio
2.22
Asset Turnover Ratio
1.12
Inventory Turnover Ratio
3.87
Receivable Turnover Ratio
8.08
Days Sales in Inventory Ratio
4 days
Gross Margin Ratio
0.6
Operating Margin Ratio
0.3
Return on Assets Ratio
0.26
Return on Equity Ratio
0.57
Book Value per Share Ratio
0.13
Earnings per Share Ratio
52.93
Histroric Financial Stats
We are finding ways to improve data quality all the time. Please report any data related issue to cliffgoslinginc@gmail.com.
20232022202120202019
Total Revenue
3.66 B
3.37 B
3.22 B
2.71 B
2.41 B
Cost of Revenue
-1.47 B
-1.36 B
-1.33 B
-1.14 B
-1.04 B
Gross Profit
2.19 B
2 B
1.89 B
1.57 B
1.37 B
Operating Expenses
-1.09 B
-1.11 B
-957.4 M
-876.52 M
-812.7 M
Total Expenses
-2.56 B
-2.47 B
-2.28 B
-2.01 B
-1.85 B
Operating Income
1.1 B
898.77 M
932.03 M
694.52 M
552.85 M
Total Other Income
-35.95 M
-38.79 M
-29.37 M
-32.54 M
-30.63 M
Pretax Income
1.06 B
859.97 M
902.65 M
661.99 M
522.22 M
Tax Provision
-212 M
-180.88 M
-157.81 M
-79.85 M
-94.43 M
Net Income Common Shareholders
0
679.09 M
744.85 M
581.78 M
427.72 M
EBIT
1.1 B
898.77 M
932.03 M
694.52 M
552.85 M
EBITDA
1.1 B
1.01 B
1.04 B
790.52 M
640.86 M
Reconciled Depreciation
-113.89 M
-111.9 M
-104.6 M
-96 M
-88.01 M
Common Stock Shares Outstanding
83.98 M
84.6 M
86.57 M
86.72 M
87.54 M
Diluted EPS
0
8.03
8.6
6.71
4.89
Minority Interest
0
0
1 k
355 k
72 k
Projected Return on Equity
Disclaimer: the predictions are generated from AI models trained on financial statements data of all US common stocks in the past 40 years.
Expected Value: 50.48%
Curve fitting error: 0.6074
Projected Return on Assets
Disclaimer: the predictions are generated from AI models trained on financial statements data of all US common stocks in the past 40 years.
Expected Value: 15.21%
Curve fitting error: 0.0091
@2024 by Times Arrow (cliffgoslinginc@gmail.com)
Terms and Conditions|Privacy